You are looking for

Small and medium sized enterprises (SMEs) are the lifeblood of the medical technology industry. Research in the medical technology industry, which typically occurs at the bedside not at the bench, is usually a result of small or micro collaborations between health professionals, academia and SMEs. This research model brings rapid innovation, which quickly tackles current and emerging medical needs. This innovation can only be good news for under-pressure European healthcare systems as there is clear evidence that more effective treatments are capable of delivering clear benefits; reduced hospital stays (with an associated reduction in cost of treatment); better outcomes, and faster rehabilitation and return to society.

Eucomed has recently submitted remote monitoring of implantable cardiac devices as one of its four proposals to the Active and Healthy Ageing Innovation Partnership under the European Commission’s Innovation Union Strategy. Such an initiative is exactly what Europe is in need of to ensure its place at the top of the innovation ladder. Eucomed selected […]

The turn of the year brings all manner of analysis of the events of one year and predictions for the year ahead. 2010 will not be fondly remembered by many as it heralded the impact of the 2008 banking crisis on the real world of citizens and business. For those in the public sector and […]

A new report by the OECD makes sobering reading as it makes the point that continued expansion of spending in developed countries is unsustainable. Reading the reported highlights, a couple of statements jumped out at me. “Healthcare costs are escalating rapidly, driven by population aging, rising relative prices and costly developments in medical technology. Public […]

Yesterday afternoon I was fortunate enough to be invited to participate in a round table discussion organised by Motorola as part of the EU Open Days conference organised by the Committee for the Regions. Entitled ‘ EU Wide Patient Safety – A Roundtable to demonstrate ways of overcoming barriers to adoption in healthcare using innovative […]

In recent weeks within the pharmaceutical industry there has been much talk of both downsizing – GSK and AstraZeneca shedding 11,000 jobs – and outsourcing of research and development, with a whole range of licensing or partnership deals designed to pad out faltering product pipelines. Once again I was prompted to think about the prospect […]

Talking about the role of the EU in the developing world EC Director General for Development Stefano Manservisi described the new approach to health development policy on a global level: “From donorship to partnership”. He explained that access to medicine needs to be viewed as not only provision of medicines but rather the ability to […]